Literature DB >> 29514050

Mechanism of aggregation and membrane interactions of mammalian prion protein.

Sabareesan Ambadi Thody1, M K Mathew1, Jayant B Udgaonkar2.   

Abstract

The cellular prion protein (PrPC), which is present ubiquitously in all mammalian neurons, is normally found to be linked to the cell membrane through a glycosylphosphatidylinositol (GPI) anchor. The conformational conversion of PrPC into misfolded and aggregated forms is associated with transmissible neurodegenerative diseases known as prion diseases. The importance of different misfolded conformations in prion diseases, and the mechanism by which prion aggregates induce neurotoxicity remain poorly understood. Multiple studies have been shown that the toxicity of misfolded prion protein is directly correlated with its ability to interact with and perturb membranes. This review describes the current progress toward understanding prion protein misfolding and aggregation, as well as the interaction of prion protein aggregates with lipid membrane.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid; Calcium homeostasis; Ion channel; Lipid membrane; Oligomer; Prion

Year:  2018        PMID: 29514050     DOI: 10.1016/j.bbamem.2018.02.031

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  10 in total

1.  Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids.

Authors:  Mansoore Esmaili; Brian P Tancowny; Xiongyao Wang; Audric Moses; Leonardo M Cortez; Valerie L Sim; Holger Wille; Michael Overduin
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

Review 2.  Cholesterol and its reciprocal association with prion infection.

Authors:  Jessica Cashion; Wanzhen Zhang; Tahir Ali; Sabine Gilch
Journal:  Cell Tissue Res       Date:  2022-07-12       Impact factor: 4.051

3.  Antibody binding modulates the dynamics of the membrane-bound prion protein.

Authors:  Ioana M Ilie; Marco Bacci; Andreas Vitalis; Amedeo Caflisch
Journal:  Biophys J       Date:  2022-06-06       Impact factor: 3.699

4.  New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding.

Authors:  Anna I Sulatskaya; Georgy N Rychkov; Maksim I Sulatsky; Ekaterina V Mikhailova; Nadezhda M Melnikova; Veronika S Andozhskaya; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

5.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

6.  Quercetin Disaggregates Prion Fibrils and Decreases Fibril-Induced Cytotoxicity and Oxidative Stress.

Authors:  Kun-Hua Yu; Cheng-I Lee
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 7.  Plasma membrane integrity: implications for health and disease.

Authors:  Dustin A Ammendolia; William M Bement; John H Brumell
Journal:  BMC Biol       Date:  2021-04-13       Impact factor: 7.431

Review 8.  The Integral Role of RNA in Stress Granule Formation and Function.

Authors:  Danae Campos-Melo; Zachary C E Hawley; Cristian A Droppelmann; Michael J Strong
Journal:  Front Cell Dev Biol       Date:  2021-05-20

Review 9.  Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.

Authors:  Larissa-Nele Schaffert; Wayne G Carter
Journal:  Brain Sci       Date:  2020-04-11

Review 10.  Structural Proteomics Methods to Interrogate the Conformations and Dynamics of Intrinsically Disordered Proteins.

Authors:  Rebecca Beveridge; Antonio N Calabrese
Journal:  Front Chem       Date:  2021-03-11       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.